Kanagawa, Japan

Takeshi Yamasaki

This inventor holds 59 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 17 EPO patents, primarily in Microchip Technology (CPC class B01L). Top assignees: Sony Corporation, Takeda Pharmaceutical Company Limited, Lintec Corporation. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeshi Yamasaki. Retrieved from https://idiyas.com/inventor/takeshi-yamasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 59 

% Patents Active = 54.2


 

Average Co-Inventor Count = 3.9

ph-index = 8

Forward Citations = 217(Granted Patents)

Forward Citations (Not Self Cited) = 191(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Kanagawa-ken, JP (2010)
  • Yokohama, JP (2011)
  • Tokyo, JP (2006 - 2021)
  • Fujisawa, JP (2017 - 2021)
  • Kanagawa, JP (1997 - 2024)
  • Osaka, JP (2009 - 2024)

Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Micro Flow Channel Chip
Laminated Battery
Optical Recording Medium
Particle Analyzing Device
Spinal Muscular Atrophy
Heterocyclic Compound
Aromatic Ring Compound
Agitator
Fine Particle Measurement
Coating Composition
Pharmaceutical Products
Microparticle Sorting
59 patents (USPTO):Explore Patents

Title: Innovations of Takeshi Yamasaki: A Pioneer in Pharmaceutical Patents

Introduction

Takeshi Yamasaki, an esteemed inventor based in Kanagawa, Japan, has made significant contributions to the field of pharmaceuticals through his innovative patents. With a remarkable portfolio of 56 patents, he has emerged as a leading figure in the development of novel therapeutic agents, particularly for spinal muscular atrophy.

Latest Patents

Among his most recent patents, Yamasaki has developed a compound aimed at treating spinal muscular atrophy. This invention includes a prophylactic or therapeutic agent represented by a specific formula, where the details of the variables are meticulously described. Another notable patent describes a process for producing a sulfonylpyrrole compound, which serves as a pharmaceutical product. This method involves a series of steps: reducing a compound, hydrolyzing the product, conducting a sulfonylation reaction, and finally an amination reaction to yield the desired compound.

Career Highlights

Takeshi Yamasaki has held positions in prominent companies, notably at Sony Corporation and Takeda Pharmaceutical Company Limited. His work in these organizations has paved the way for groundbreaking advancements in drug development and pharmaceutical innovation. His dedication and expertise have consistently brought forth new possibilities in the treatment of various medical conditions.

Collaborations

Throughout his career, Yamasaki has collaborated with talented individuals, including coworkers such as Tomomi Yukumoto and Shoji Akiyama. These collaborative efforts have further enriched his work and have contributed to the successful development of his many patents and innovations.

Conclusion

With his extensive experience and a strong foundation in pharmaceutical research, Takeshi Yamasaki continues to be a vital player in the world of innovation. His patents not only showcase his inventiveness but also highlight his commitment to improving therapies for difficult-to-treat health conditions. As he moves forward, the impact of his contributions will undoubtedly continue to resonate in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…